Corriente Advisors, LLC Dia Medica Therapeutics Inc. Transaction History

Corriente Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.1 - $4.32 $631,287 - $879,729	-203,641 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$4.45 - $9.91 $2.97 Million - $6.61 Million	-666,587 Reduced 76.6%	203,641 $906,000
Q1 2021 May 18, 2021	BUY	$7.76 - $10.43 $491,425 - $660,511	63,328 Added 7.85%	870,228 $7.96 Million
Q4 2020 Feb 16, 2021	BUY	$4.13 - $10.14 $317,597 - $779,766	76,900 Added 10.53%	806,900 $8.18 Million
Q3 2020 Nov 03, 2020	BUY	$3.91 - $7.15 $2.07 Million - $3.78 Million	528,752 Added 262.74%	730,000 $3.1 Million
Q2 2020 Aug 14, 2020	BUY	$2.6 - $7.32 $523,244 - $1.47 Million	201,248 New	201,248 $1.4 Million

3.87M

1.3K

Ticker DMAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,443,100
Market Cap $116M
Description
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...

Get notified when there are updates to the investment portfolio of Corriente Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Corriente Advisors, LLC with notifications on news.